R&D Systems™ Recombinant Human Siglec-9 Fc Chimera Protein

Catalog No.	Quantity
1139SL050	50 μg

Catalog No. 1139SL050 Supplier R&D Systems™ Supplier No. 1139SL050

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

Measured by the ability of the immobilized protein to support the adhesion of human red blood cells. Kelm, S. et al. (1994) Current Biology 4:965. The ED50 for this effect is 10.0-100 ng/mL.

Specifications

• Accession Number: Q9Y336
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 27180
• Molecular Weight (g/mol): M.W. (Observed): 90-100 kDa, reducing conditions; M.W. (theoretical): 62.7 kDa (monomer)
• Name: Siglec-9 Fc Chimera
• Quantity: 50 μg
• Source: Mouse myeloma cell line, NS0-derived human Siglec-9 protein Human Siglec-9 (Gln18-Gly348) (N-terminus) Accession # Q9Y336 DIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Structural Form: Disulfide-linked homodimer
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Gene Symbol: SIGLEC9
• Conjugate: Unconjugated
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 μg/mL in sterile PBS.
• Purity or Quality Grade: >97%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining.
• Protein: Siglec-9